ENTITY
Celltrion

Celltrion (068270 KP)

21
Analysis
Health CareSouth Korea
Celltrion, Inc. produces and sells biosimilar products, as well as consignment processing services for other businesses.
more
Refresh
bullishCelltrion Inc
30 Jan 2018 20:45

Impact Analysis of Celltrion's KOSPI Move on KOSPI 200 and KOSDAQ 150

The KRX senior official named Lee Eun-tae had a press conference yesterday (Jan 29). He gave the major projects that the KRX is currently planning...

Logo
396 Views
Share
bullishCelltrion Inc
05 Jan 2018 12:28

Celltrion (068270 KS): Korean Making Biological Drugs for the West

Solid long-term sales growth, strong sales momentum, and high earnings quality relative to its sector Celltrion is one of Korea’s top exporters of...

Share
25 Nov 2017 21:53

Summary of KOSDAQ 150 December Reshuffle & Rebalancing

It was officially announced that a total of 13 stocks would be newly added to KOSDAQ 150 in the upcoming periodical reshuffle, whereas the same...

Logo
506 Views
Share
16 Nov 2017 22:57

KOSDAQ's Bullish Run - Main Drivers & Stocks to Pick

KOSDAQ is getting really hot. Over the past three months, KOSDAQ index climbed 22.89% by 145.31 points from 642.11 on Aug 17 to 780.22 today on Nov...

Logo
628 Views
Share
09 Nov 2017 16:52

Korea, Kospi 200: Targeting 400+

The MSCI Asia Free ex-Japan (MXASJ – 703) regional benchmark, is expected to exceed 1,080 before the bull market that started in 2016 ends, that’s...

Logo
132 Views
Share
x